Nybo Therapeutics

Nybo Therapeutics is an AI-driven biotechnology company focused on accelerating the discovery and development of precision medicines. The company utilizes a proprietary computational platform that integrates high-dimensional biological data with machine learning to identify novel therapeutic targets and optimize drug candidates. Founded by industry veterans with expertise in data science and drug development, Nybo aims to bridge the gap between big data and clinical success. Their primary focus is on developing small molecule candidates for oncology, cardiovascular disease, and other high-need therapeutic areas. By leveraging a "biology-first" approach, the company seeks to optimize lead discovery and improve patient stratification in clinical trials.